🚀 VC round data is live in beta, check it out!
Mater Dei Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mater Dei and similar public comparables like Auna, M1 Kliniken, Pihlajalinna, Medica Sur and more.
Mater Dei Overview
About Mater Dei
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
Founded
1980
HQ
Employees
3.7K
Website
Sectors
Financials (LTM)
EV
$659M
Mater Dei Financials
Mater Dei reported last 12-month revenue of $420M and EBITDA of $88M.
In the same LTM period, Mater Dei generated $126M in gross profit, $88M in EBITDA, and $23M in net income.
Revenue (LTM)
Mater Dei P&L
In the most recent fiscal year, Mater Dei reported revenue of $423M and EBITDA of ($30M).
Mater Dei expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $420M | XXX | $423M | XXX | XXX | XXX |
| Gross Profit | $126M | XXX | $127M | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $88M | XXX | ($30M) | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | (7%) | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $23M | XXX | ($58M) | XXX | XXX | XXX |
| Net Margin | 5% | XXX | (14%) | XXX | XXX | XXX |
| Net Debt | — | — | $152M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mater Dei Stock Performance
Mater Dei has current market cap of $376M, and enterprise value of $659M.
Market Cap Evolution
Mater Dei's stock price is $1.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $659M | $376M | (0.6%) | XXX | XXX | XXX | $-0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMater Dei Valuation Multiples
Mater Dei trades at 1.6x EV/Revenue multiple, and 7.5x EV/EBITDA.
EV / Revenue (LTM)
Mater Dei Financial Valuation Multiples
As of March 7, 2026, Mater Dei has market cap of $376M and EV of $659M.
Equity research analysts estimate Mater Dei's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mater Dei has a P/E ratio of 16.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $376M | XXX | $376M | XXX | XXX | XXX |
| EV (current) | $659M | XXX | $659M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.5x | XXX | (22.3x) | XXX | XXX | XXX |
| EV/EBIT | 9.6x | XXX | 10.1x | XXX | XXX | XXX |
| EV/Gross Profit | 5.2x | XXX | 5.2x | XXX | XXX | XXX |
| P/E | 16.6x | XXX | (6.5x) | XXX | XXX | XXX |
| EV/FCF | 21.8x | XXX | 6.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mater Dei Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mater Dei Margins & Growth Rates
Mater Dei's revenue in the last 12 month grew by 11%.
Mater Dei's revenue per employee in the last FY averaged $0.1M.
Mater Dei's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mater Dei's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mater Dei Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | (388%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mater Dei Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Auna | XXX | XXX | XXX | XXX | XXX | XXX |
| M1 Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Pihlajalinna | XXX | XXX | XXX | XXX | XXX | XXX |
| Medica Sur | XXX | XXX | XXX | XXX | XXX | XXX |
| Sikarin | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mater Dei M&A Activity
Mater Dei acquired XXX companies to date.
Last acquisition by Mater Dei was on XXXXXXXX, XXXXX. Mater Dei acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mater Dei
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMater Dei Investment Activity
Mater Dei invested in XXX companies to date.
Mater Dei made its latest investment on XXXXXXXX, XXXXX. Mater Dei invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mater Dei
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mater Dei
| When was Mater Dei founded? | Mater Dei was founded in 1980. |
| Where is Mater Dei headquartered? | Mater Dei is headquartered in Brazil. |
| How many employees does Mater Dei have? | As of today, Mater Dei has over 3K employees. |
| Who is the CEO of Mater Dei? | Mater Dei's CEO is Henrique Moraes Salvador Silva. |
| Is Mater Dei publicly listed? | Yes, Mater Dei is a public company listed on B3. |
| What is the stock symbol of Mater Dei? | Mater Dei trades under MATD3 ticker. |
| When did Mater Dei go public? | Mater Dei went public in 2021. |
| Who are competitors of Mater Dei? | Mater Dei main competitors are Auna, M1 Kliniken, Pihlajalinna, Medica Sur. |
| What is the current market cap of Mater Dei? | Mater Dei's current market cap is $376M. |
| What is the current revenue of Mater Dei? | Mater Dei's last 12 months revenue is $420M. |
| What is the current revenue growth of Mater Dei? | Mater Dei revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Mater Dei? | Current revenue multiple of Mater Dei is 1.6x. |
| Is Mater Dei profitable? | Yes, Mater Dei is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mater Dei? | Mater Dei's last 12 months EBITDA is $88M. |
| What is Mater Dei's EBITDA margin? | Mater Dei's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Mater Dei? | Current EBITDA multiple of Mater Dei is 7.5x. |
| What is the current FCF of Mater Dei? | Mater Dei's last 12 months FCF is $30M. |
| What is Mater Dei's FCF margin? | Mater Dei's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Mater Dei? | Current FCF multiple of Mater Dei is 21.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.